Patent · US Active

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

US7968589B2 · kind B2 · utility

4Cited by

7References

3Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

John E. Stelmach · Westfield, US
Emma R. Parmee · Scotch Plains, US
James R. Tata · Westfield, US
Keith Rosauer · New Hampton, US
Ronald Kim · Essen, DE
Amy R. Bittner · Scotch Plains, US
Jiang Chang · Beijing, CN
Christopher Joseph Sinz · Middletown, US

Key dates

Filing date	Feb 9, 2010
Grant date	Jun 28, 2011
Priority date	—
Expiry date	Feb 9, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.